Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
X Squared Angels
AddedMar 19, 2024
UpdatedJul 22, 2026
X Squared Angels

X Squared Angels

Operating

Rev1 Ventures: Investor startup studio in the Midwest, helping startups scale and corporates innovate.

Location
Columbus, OH, US
Founded
2013
Firm
Compare
Portfolio
Fundraising
Employees
Website

Investments

Basking Biosciences
Basking Biosciences

Total Raised

$89.8M

Rounds

5

Series Unknown$55MJanuary 2024
Seed$5.4MDecember 2020
Clarametyx Biosciences
Clarametyx Biosciences

Total Raised

$59.2M

Rounds

6

Series A$33MJanuary 2024
SeedNovember 2022
Lentechs
Lentechs

Total Raised

$11.1M

Rounds

5

Series Unknown$6MOctober 2023
ConverSight.ai
ConverSight.ai
Series A

Total Raised

$16M

Rounds

8

Series A$9MAugust 2023
Debt$4MJanuary 2022
Print Syndicate
Print Syndicate

Total Raised

$6.3M

Rounds

6

UndisclosedAugust 2023
Invirsa
Invirsa

Total Raised

$16.1M

Rounds

5

Series B$7.7MJune 2023
MentorcliQ
MentorcliQ

Total Raised

$91.3M

Rounds

6

Series Unknown$80MMarch 2023
ZapIT
ZapIT

Total Raised

$2.9M

Rounds

3

SeedFebruary 2023
Seed$1.5MSeptember 2022
Synota
Synota

Total Raised

$3M

Rounds

1

Seed$3MOctober 2022
Upshift
Upshift

Total Raised

$6M

Rounds

4

Series BOctober 2022
Speedwell & Yarrow
Speedwell & Yarrow

Total Raised

$2M

Rounds

4

Seed$245kOctober 2022
Redi.Health
Redi.Health

Total Raised

$5M

Rounds

2

Series A$3.7MAugust 2022
Seed$1.3MAugust 2021
Staq Pharma
Staq Pharma

Total Raised

$19.1M

Rounds

3

Series CMarch 2022
Lucy
Lucy

Total Raised

$5.5M

Rounds

3

Series A$2.5MJanuary 2022
HDO Health
HDO Health

Total Raised

$451k

Rounds

4

Angel$75kJanuary 2022
Healthy Roster
Healthy Roster

Total Raised

$6.9M

Rounds

5

Convertible Note$2.1MOctober 2021
Aware
Aware

Total Raised

$87.1M

Rounds

8

Series C$60MOctober 2021
Series B$12MDecember 2020
Driver
Driver

Total Raised

$16.3M

Rounds

4

Series A$8MJune 2021
Eikonoklastes Therapeutics
Eikonoklastes Therapeutics

Total Raised

$6M

Rounds

2

Series A$3.2MMay 2021